Ancera has unveiled the release of two new microbial detection tools designed to identify and enumerate Clostridium perfringens and total viable bacteria (TVB) in poultry. The assays are designed to address critical challenges within the poultry industry, from live operations to processing, and help companies increase productivity, food safety, and interventional efficacy.

Ancera’s TVB assay is the first true non-enrichment, microbial quantitation assay focused on same-shift process improvement and quality control at the plant. The tool provides quantifiable microbial information enabling integrators to understand whether their processes are working to reduce microbial load. Once fully commercialized, the technology will produce results within a single working shift, unlocking real-time trend analysis and decision-making for improved compliance and sanitation. The new assay represents a significant reduction from traditional 48–72 hour turnaround times, decreasing the risk of compliance and recall risk.

Additionally, Ancera’s Clostridium assay specifically enumerates and monitors Clostridium perfringens, the causative agent of necrotic enteritis (NE) in poultry. The assay will help integrators to determine and track Clostridium load in their system, providing additional visibility of impact on key production metrics and overall animal health. The monitoring technique also has implications for assessing intervention effectiveness in certain animal welfare programs. When combined with Ancera’s Coccidia System Monitoring (CSM) and advanced analytical capabilities, Coccidia oocyst and Clostridium load tracking in near real-time provides comprehensive insight into the effects of gut health on production.

The new assays will be made available in 2024 to a limited set of trial customers to generate user feedback and accelerate a fully commercialized software product.